Literature DB >> 15752158

Nucleic acid test screening of blood donors for orthopoxviruses can potentially prevent dispersion of viral agents in case of bioterrorism.

Michael Schmidt1, W Kurt Roth, Hermann Meyer, Erhard Seifried, Michael K Hourfar.   

Abstract

BACKGROUND: Microbiologic agents such as variola virus (VAR) are very attractive for terrorism. As a result of international collaboration under the WHO eradication campaign, smallpox was declared eradicated in 1980. Therefore, the immunization programs were discontinued worldwide. Because most people are now immunologically naive, VAR is considered to be a potential threat agent or bioterrorist weapon. Real-time polymerase chain reaction (PCR) followed by melting analysis was developed for fast and safe analysis and allows differentiation of VAR from other orthopoxviruses (OPVs) like vaccinia or camelpox virus. STUDY DESIGN AND METHODS: A RealArt Orthopox LC PCR kit (Artus GmbH) was used to amplify OPV sequences from blood donor samples. A total of 31,500 blood donor samples were tested in minipools of up to 96 samples. To evaluate the sensitivity of the assay, routine donor minipools (90 +/- 6 samples per pool) were spiked with vaccinia virus used as positive control.
RESULTS: Specificity was 100 percent because none of 31,500 blood donors was positive for the presence OPV. The detection limit of the assay was 10.6 copies per PCR procedure. Therefore, a sensitivity of 1590 copies per mL was calculated. Overall, 0.28 percent of test results had to be considered invalid owing to negative internal controls.
CONCLUSION: The RealArt Orthopox LC PCR kit enables reliable detection of OPV DNA in viremic blood donor samples, even at the beginning of the disease when patients present minor clinical symptoms, and could be implemented in our routine screening procedure immediately. Thus, the assay could potentially help to prevent dispersion of viral agents by blood transfusion in case of bioterrorism.

Entities:  

Mesh:

Year:  2005        PMID: 15752158     DOI: 10.1111/j.1537-2995.2005.04242.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  6 in total

1.  Orthopox Viruses: Infections in Humans.

Authors:  Georg Pauli; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen; Carl-Heinz Wirsing von König
Journal:  Transfus Med Hemother       Date:  2010-11-17       Impact factor: 3.747

2.  Regression models for group testing data with pool dilution effects.

Authors:  Christopher S McMahan; Joshua M Tebbs; Christopher R Bilder
Journal:  Biostatistics       Date:  2012-11-28       Impact factor: 5.899

3.  A general framework for the regression analysis of pooled biomarker assessments.

Authors:  Yan Liu; Christopher McMahan; Colin Gallagher
Journal:  Stat Med       Date:  2017-03-28       Impact factor: 2.373

4.  Informative Dorfman screening.

Authors:  Christopher S McMahan; Joshua M Tebbs; Christopher R Bilder
Journal:  Biometrics       Date:  2011-07-15       Impact factor: 2.571

5.  Informative Retesting.

Authors:  Christopher R Bilder; Joshua M Tebbs; Peng Chen
Journal:  J Am Stat Assoc       Date:  2010-09-01       Impact factor: 5.033

6.  Capturing the pool dilution effect in group testing regression: A Bayesian approach.

Authors:  Stella Self; Christopher McMahan; Stefani Mokalled
Journal:  Stat Med       Date:  2022-07-25       Impact factor: 2.497

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.